+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Genomics Market in US 2023-2027

  • PDF Icon

    Report

  • 145 Pages
  • October 2023
  • Region: United States
  • TechNavio
  • ID: 5892844
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The genomics market in US is forecasted to grow by USD 5,284.67 mn during 2022-2027, accelerating at a CAGR of 10.45% during the forecast period. The report on the genomics market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by a reduction in the cost of genetic sequencing, increasing demand for creating and upgrading genome databases, and growing demand for personalized medicine.

The genomics market in US is segmented as below:

By Application

  • Diagnostic
  • Drug discovery
  • Others

By End-user

  • Hospitals and clinics
  • Academic and research institutes
  • Pharmaceutical and biotechnology companies
  • Others

By Solution

  • Products
  • Services
This study identifies the growing adoption of single cell-based genomics analysis as one of the prime reasons driving the genomics market in US growth during the next few years. Also, advances in sequencing technologies and growing applications of genomics in oncology will lead to sizable demand in the market.

The report on the genomics market in US covers the following areas:

  • Genomics market in US sizing
  • Genomics market in US forecast
  • Genomics market in US industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading genomics market in US vendors that include Agilent Technologies Inc., BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Caris Life Sciences, CENTOGENE NV, Color Health Inc., Danaher Corp., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Illumina Inc., Invitae Corp., LetsGetChecked, Myriad Genetics Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., PerkinElmer Inc., Personalis Inc., QIAGEN NV, Thermo Fisher Scientific Inc., and Twist Bioscience Corp.. Also, the genomics market in US analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Country Market Characteristics
Exhibit 04: Executive Summary - Chart on Market Segmentation by Application
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Solution
Exhibit 07: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 08: Parent market
Exhibit 09: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 10: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 11: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 12: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 13: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 14: Chart on US: Year-over-year growth 2022-2027 (%)
Exhibit 15: Data Table on US: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Genomics market in US 2017 - 2021
Exhibit 16: Historic Market Size - Data Table on genomics market in US 2017 - 2021 ($ million)
4.2 Application Segment Analysis 2017 - 2021
Exhibit 17: Historic Market Size - Application Segment 2017 - 2021 ($ million)
4.3 End-user Segment Analysis 2017 - 2021
Exhibit 18: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
4.4 Solution Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Solution Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 20: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 21: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 22: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 23: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 24: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 25: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 26: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Application
6.1 Market segments
Exhibit 27: Chart on Application - Market share 2022-2027 (%)
Exhibit 28: Data Table on Application - Market share 2022-2027 (%)
6.2 Comparison by Application
Exhibit 29: Chart on Comparison by Application
Exhibit 30: Data Table on Comparison by Application
6.3 Diagnostic - Market size and forecast 2022-2027
Exhibit 31: Chart on Diagnostic - Market size and forecast 2022-2027 ($ million)
Exhibit 32: Data Table on Diagnostic - Market size and forecast 2022-2027 ($ million)
Exhibit 33: Chart on Diagnostic - Year-over-year growth 2022-2027 (%)
Exhibit 34: Data Table on Diagnostic - Year-over-year growth 2022-2027 (%)
6.4 Drug discovery - Market size and forecast 2022-2027
Exhibit 35: Chart on Drug discovery - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Data Table on Drug discovery - Market size and forecast 2022-2027 ($ million)
Exhibit 37: Chart on Drug discovery - Year-over-year growth 2022-2027 (%)
Exhibit 38: Data Table on Drug discovery - Year-over-year growth 2022-2027 (%)
6.5 Others - Market size and forecast 2022-2027
Exhibit 39: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 41: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 42: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Application
Exhibit 43: Market opportunity by Application ($ million)
Exhibit 44: Data Table on Market opportunity by Application ($ million)
7 Market Segmentation by End-user
7.1 Market segments
Exhibit 45: Chart on End-user - Market share 2022-2027 (%)
Exhibit 46: Data Table on End-user - Market share 2022-2027 (%)
7.2 Comparison by End-user
Exhibit 47: Chart on Comparison by End-user
Exhibit 48: Data Table on Comparison by End-user
7.3 Hospitals and clinics - Market size and forecast 2022-2027
Exhibit 49: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 51: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
Exhibit 52: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
7.4 Academic and research institutes - Market size and forecast 2022-2027
Exhibit 53: Chart on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Data Table on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
Exhibit 55: Chart on Academic and research institutes - Year-over-year growth 2022-2027 (%)
Exhibit 56: Data Table on Academic and research institutes - Year-over-year growth 2022-2027 (%)
7.5 Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027
Exhibit 57: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
Exhibit 59: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
Exhibit 60: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
7.6 Others - Market size and forecast 2022-2027
Exhibit 61: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 63: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 64: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.7 Market opportunity by End-user
Exhibit 65: Market opportunity by End-user ($ million)
Exhibit 66: Data Table on Market opportunity by End-user ($ million)
8 Market Segmentation by Solution
8.1 Market segments
Exhibit 67: Chart on Solution - Market share 2022-2027 (%)
Exhibit 68: Data Table on Solution - Market share 2022-2027 (%)
8.2 Comparison by Solution
Exhibit 69: Chart on Comparison by Solution
Exhibit 70: Data Table on Comparison by Solution
8.3 Products - Market size and forecast 2022-2027
Exhibit 71: Chart on Products - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Products - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Products - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Products - Year-over-year growth 2022-2027 (%)
8.4 Services - Market size and forecast 2022-2027
Exhibit 75: Chart on Services - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Services - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Services - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Services - Year-over-year growth 2022-2027 (%)
8.5 Market opportunity by Solution
Exhibit 79: Market opportunity by Solution ($ million)
Exhibit 80: Data Table on Market opportunity by Solution ($ million)
9 Customer Landscape
9.1 Customer landscape overview
Exhibit 81: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 82: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 83: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 84: Overview on factors of disruption
11.4 Industry risks
Exhibit 85: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 86: Vendors covered
12.2 Market positioning of vendors
Exhibit 87: Matrix on vendor position and classification
12.3 Agilent Technologies Inc.
Exhibit 88: Agilent Technologies Inc. - Overview
Exhibit 89: Agilent Technologies Inc. - Business segments
Exhibit 90: Agilent Technologies Inc. - Key offerings
Exhibit 91: Agilent Technologies Inc. - Segment focus
12.4 BGI Genomics Co. Ltd.
Exhibit 92: BGI Genomics Co. Ltd. - Overview
Exhibit 93: BGI Genomics Co. Ltd. - Product/Service
Exhibit 94: BGI Genomics Co. Ltd. - Key offerings
12.5 Bio Rad Laboratories Inc.
Exhibit 95: Bio Rad Laboratories Inc. - Overview
Exhibit 96: Bio Rad Laboratories Inc. - Business segments
Exhibit 97: Bio Rad Laboratories Inc. - Key news
Exhibit 98: Bio Rad Laboratories Inc. - Key offerings
Exhibit 99: Bio Rad Laboratories Inc. - Segment focus
12.6 Color Health Inc.
Exhibit 100: Color Health Inc. - Overview
Exhibit 101: Color Health Inc. - Product/Service
Exhibit 102: Color Health Inc. - Key offerings
12.7 Danaher Corp.
Exhibit 103: Danaher Corp. - Overview
Exhibit 104: Danaher Corp. - Business segments
Exhibit 105: Danaher Corp. - Key news
Exhibit 106: Danaher Corp. - Key offerings
Exhibit 107: Danaher Corp. - Segment focus
12.8 F. Hoffmann La Roche Ltd.
Exhibit 108: F. Hoffmann La Roche Ltd. - Overview
Exhibit 109: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 110: F. Hoffmann La Roche Ltd. - Key news
Exhibit 111: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 112: F. Hoffmann La Roche Ltd. - Segment focus
12.9 Illumina Inc.
Exhibit 113: Illumina Inc. - Overview
Exhibit 114: Illumina Inc. - Business segments
Exhibit 115: Illumina Inc. - Key news
Exhibit 116: Illumina Inc. - Key offerings
Exhibit 117: Illumina Inc. - Segment focus
12.10 LetsGetChecked
Exhibit 118: LetsGetChecked - Overview
Exhibit 119: LetsGetChecked - Product/Service
Exhibit 120: LetsGetChecked - Key offerings
12.11 Myriad Genetics Inc.
Exhibit 121: Myriad Genetics Inc. - Overview
Exhibit 122: Myriad Genetics Inc. - Product/Service
Exhibit 123: Myriad Genetics Inc. - Key offerings
12.12 Oxford Nanopore Technologies plc
Exhibit 124: Oxford Nanopore Technologies plc - Overview
Exhibit 125: Oxford Nanopore Technologies plc - Product/Service
Exhibit 126: Oxford Nanopore Technologies plc - Key offerings
12.13 Pacific Biosciences of California Inc.
Exhibit 127: Pacific Biosciences of California Inc. - Overview
Exhibit 128: Pacific Biosciences of California Inc. - Product/Service
Exhibit 129: Pacific Biosciences of California Inc. - Key offerings
12.14 PerkinElmer Inc.
Exhibit 130: PerkinElmer Inc. - Overview
Exhibit 131: PerkinElmer Inc. - Business segments
Exhibit 132: PerkinElmer Inc. - Key news
Exhibit 133: PerkinElmer Inc. - Key offerings
Exhibit 134: PerkinElmer Inc. - Segment focus
12.15 QIAGEN NV
Exhibit 135: QIAGEN NV - Overview
Exhibit 136: QIAGEN NV - Product/Service
Exhibit 137: QIAGEN NV - Key news
Exhibit 138: QIAGEN NV - Key offerings
12.16 Thermo Fisher Scientific Inc.
Exhibit 139: Thermo Fisher Scientific Inc. - Overview
Exhibit 140: Thermo Fisher Scientific Inc. - Business segments
Exhibit 141: Thermo Fisher Scientific Inc. - Key news
Exhibit 142: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 143: Thermo Fisher Scientific Inc. - Segment focus
12.17 Twist Bioscience Corp.
Exhibit 144: Twist Bioscience Corp. - Overview
Exhibit 145: Twist Bioscience Corp. - Product/Service
Exhibit 146: Twist Bioscience Corp. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 147: Inclusions checklist
Exhibit 148: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 149: Currency conversion rates for US$
13.4 Research methodology
Exhibit 150: Research methodology
Exhibit 151: Validation techniques employed for market sizing
Exhibit 152: Information sources
13.5 List of abbreviations
Exhibit 153: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Country Market Characteristics
Exhibits 4: Executive Summary - Chart on Market Segmentation by Application
Exhibits 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary - Chart on Market Segmentation by Solution
Exhibits 7: Executive Summary - Chart on Vendor Market Positioning
Exhibits 8: Parent market
Exhibits 9: Market Characteristics
Exhibits 10: Offerings of vendors included in the market definition
Exhibits 11: Market segments
Exhibits 12: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 13: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 14: Chart on US: Year-over-year growth 2022-2027 (%)
Exhibits 15: Data Table on US: Year-over-year growth 2022-2027 (%)
Exhibits 16: Historic Market Size - Data Table on genomics market in US 2017 - 2021 ($ million)
Exhibits 17: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits 18: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Solution Segment 2017 - 2021 ($ million)
Exhibits 20: Five forces analysis - Comparison between 2022 and 2027
Exhibits 21: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 22: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 23: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 24: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 25: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 26: Chart on Market condition - Five forces 2022 and 2027
Exhibits 27: Chart on Application - Market share 2022-2027 (%)
Exhibits 28: Data Table on Application - Market share 2022-2027 (%)
Exhibits 29: Chart on Comparison by Application
Exhibits 30: Data Table on Comparison by Application
Exhibits 31: Chart on Diagnostic - Market size and forecast 2022-2027 ($ million)
Exhibits 32: Data Table on Diagnostic - Market size and forecast 2022-2027 ($ million)
Exhibits 33: Chart on Diagnostic - Year-over-year growth 2022-2027 (%)
Exhibits 34: Data Table on Diagnostic - Year-over-year growth 2022-2027 (%)
Exhibits 35: Chart on Drug discovery - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Data Table on Drug discovery - Market size and forecast 2022-2027 ($ million)
Exhibits 37: Chart on Drug discovery - Year-over-year growth 2022-2027 (%)
Exhibits 38: Data Table on Drug discovery - Year-over-year growth 2022-2027 (%)
Exhibits 39: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 41: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 42: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 43: Market opportunity by Application ($ million)
Exhibits 44: Data Table on Market opportunity by Application ($ million)
Exhibits 45: Chart on End-user - Market share 2022-2027 (%)
Exhibits 46: Data Table on End-user - Market share 2022-2027 (%)
Exhibits 47: Chart on Comparison by End-user
Exhibits 48: Data Table on Comparison by End-user
Exhibits 49: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
Exhibits 50: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
Exhibits 51: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
Exhibits 52: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
Exhibits 53: Chart on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
Exhibits 54: Data Table on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
Exhibits 55: Chart on Academic and research institutes - Year-over-year growth 2022-2027 (%)
Exhibits 56: Data Table on Academic and research institutes - Year-over-year growth 2022-2027 (%)
Exhibits 57: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
Exhibits 58: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
Exhibits 59: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
Exhibits 60: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
Exhibits 61: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 62: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 63: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 64: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 65: Market opportunity by End-user ($ million)
Exhibits 66: Data Table on Market opportunity by End-user ($ million)
Exhibits 67: Chart on Solution - Market share 2022-2027 (%)
Exhibits 68: Data Table on Solution - Market share 2022-2027 (%)
Exhibits 69: Chart on Comparison by Solution
Exhibits 70: Data Table on Comparison by Solution
Exhibits 71: Chart on Products - Market size and forecast 2022-2027 ($ million)
Exhibits 72: Data Table on Products - Market size and forecast 2022-2027 ($ million)
Exhibits 73: Chart on Products - Year-over-year growth 2022-2027 (%)
Exhibits 74: Data Table on Products - Year-over-year growth 2022-2027 (%)
Exhibits 75: Chart on Services - Market size and forecast 2022-2027 ($ million)
Exhibits 76: Data Table on Services - Market size and forecast 2022-2027 ($ million)
Exhibits 77: Chart on Services - Year-over-year growth 2022-2027 (%)
Exhibits 78: Data Table on Services - Year-over-year growth 2022-2027 (%)
Exhibits 79: Market opportunity by Solution ($ million)
Exhibits 80: Data Table on Market opportunity by Solution ($ million)
Exhibits 81: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 82: Impact of drivers and challenges in 2022 and 2027
Exhibits 83: Overview on Criticality of inputs and Factors of differentiation
Exhibits 84: Overview on factors of disruption
Exhibits 85: Impact of key risks on business
Exhibits 86: Vendors covered
Exhibits 87: Matrix on vendor position and classification
Exhibits 88: Agilent Technologies Inc. - Overview
Exhibits 89: Agilent Technologies Inc. - Business segments
Exhibits 90: Agilent Technologies Inc. - Key offerings
Exhibits 91: Agilent Technologies Inc. - Segment focus
Exhibits 92: BGI Genomics Co. Ltd. - Overview
Exhibits 93: BGI Genomics Co. Ltd. - Product/Service
Exhibits 94: BGI Genomics Co. Ltd. - Key offerings
Exhibits 95: Bio Rad Laboratories Inc. - Overview
Exhibits 96: Bio Rad Laboratories Inc. - Business segments
Exhibits 97: Bio Rad Laboratories Inc. - Key news
Exhibits 98: Bio Rad Laboratories Inc. - Key offerings
Exhibits 99: Bio Rad Laboratories Inc. - Segment focus
Exhibits 100: Color Health Inc. - Overview
Exhibits 101: Color Health Inc. - Product/Service
Exhibits 102: Color Health Inc. - Key offerings
Exhibits 103: Danaher Corp. - Overview
Exhibits 104: Danaher Corp. - Business segments
Exhibits 105: Danaher Corp. - Key news
Exhibits 106: Danaher Corp. - Key offerings
Exhibits 107: Danaher Corp. - Segment focus
Exhibits 108: F. Hoffmann La Roche Ltd. - Overview
Exhibits 109: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 110: F. Hoffmann La Roche Ltd. - Key news
Exhibits 111: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 112: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 113: Illumina Inc. - Overview
Exhibits 114: Illumina Inc. - Business segments
Exhibits 115: Illumina Inc. - Key news
Exhibits 116: Illumina Inc. - Key offerings
Exhibits 117: Illumina Inc. - Segment focus
Exhibits 118: LetsGetChecked - Overview
Exhibits 119: LetsGetChecked - Product/Service
Exhibits 120: LetsGetChecked - Key offerings
Exhibits 121: Myriad Genetics Inc. - Overview
Exhibits 122: Myriad Genetics Inc. - Product/Service
Exhibits 123: Myriad Genetics Inc. - Key offerings
Exhibits 124: Oxford Nanopore Technologies plc - Overview
Exhibits 125: Oxford Nanopore Technologies plc - Product/Service
Exhibits 126: Oxford Nanopore Technologies plc - Key offerings
Exhibits 127: Pacific Biosciences of California Inc. - Overview
Exhibits 128: Pacific Biosciences of California Inc. - Product/Service
Exhibits 129: Pacific Biosciences of California Inc. - Key offerings
Exhibits 130: PerkinElmer Inc. - Overview
Exhibits 131: PerkinElmer Inc. - Business segments
Exhibits 132: PerkinElmer Inc. - Key news
Exhibits 133: PerkinElmer Inc. - Key offerings
Exhibits 134: PerkinElmer Inc. - Segment focus
Exhibits 135: QIAGEN NV - Overview
Exhibits 136: QIAGEN NV - Product/Service
Exhibits 137: QIAGEN NV - Key news
Exhibits 138: QIAGEN NV - Key offerings
Exhibits 139: Thermo Fisher Scientific Inc. - Overview
Exhibits 140: Thermo Fisher Scientific Inc. - Business segments
Exhibits 141: Thermo Fisher Scientific Inc. - Key news
Exhibits 142: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 143: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 144: Twist Bioscience Corp. - Overview
Exhibits 145: Twist Bioscience Corp. - Product/Service
Exhibits 146: Twist Bioscience Corp. - Key offerings
Exhibits 147: Inclusions checklist
Exhibits 148: Exclusions checklist
Exhibits 149: Currency conversion rates for US$
Exhibits 150: Research methodology
Exhibits 151: Validation techniques employed for market sizing
Exhibits 152: Information sources
Exhibits 153: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global genomics market in US: Agilent Technologies Inc., BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Caris Life Sciences, CENTOGENE NV, Color Health Inc., Danaher Corp., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Illumina Inc., Invitae Corp., LetsGetChecked, Myriad Genetics Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., PerkinElmer Inc., Personalis Inc., QIAGEN NV, Thermo Fisher Scientific Inc., and Twist Bioscience Corp..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is growing adoption of single cell-based genomics analysis.'

According to the report, one of the major drivers for this market is the reduction in cost of genetic sequencing.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Agilent Technologies Inc.
  • BGI Genomics Co. Ltd.
  • Bio Rad Laboratories Inc.
  • Caris Life Sciences
  • CENTOGENE NV
  • Color Health Inc.
  • Danaher Corp.
  • Eurofins Scientific SE
  • F. Hoffmann La Roche Ltd.
  • Illumina Inc.
  • Invitae Corp.
  • LetsGetChecked
  • Myriad Genetics Inc.
  • Oxford Nanopore Technologies plc
  • Pacific Biosciences of California Inc.
  • PerkinElmer Inc.
  • Personalis Inc.
  • QIAGEN NV
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corp.

Related Topics

Related Reports

Genomics - Global Strategic Business Report - Product Image

Genomics - Global Strategic Business Report

  • Report
  • 292 Pages
  • Global
From
Genomics Market Report by Component, Application, Technology, End-User, and Region 2024-2032 - Product Image

Genomics Market Report by Component, Application, Technology, End-User, and Region 2024-2032

  • Report
  • 145 Pages
  • Global
From
Global Spatial Genomics and Transcriptomics Market 2024-2028 - Product Image

Global Spatial Genomics and Transcriptomics Market 2024-2028

  • Report
  • 162 Pages
  • Global
From
Global DNA Sequencing Market 2024-2028 - Product Image

Global DNA Sequencing Market 2024-2028

  • Report
  • 175 Pages
  • Global
From
Genetic Testing Markets. Global Market Analysis with Forecasts by Applications, Technologies, Products and Users with Executive and Consultant Guides 2023 to 2027 - Product Image

Genetic Testing Markets. Global Market Analysis with Forecasts by Applications, Technologies, Products and Users with Executive and Consultant Guides 2023 to 2027

  • Report
  • 490 Pages
  • Global
From

About the Genomics Market

The Genomics market is a sector of the biotechnology industry that focuses on the study of genomes, or the complete set of genetic material present in a living organism. It involves the sequencing, analysis, and manipulation of genetic material to understand the structure and function of genes, as well as their interactions with the environment. Genomics research is used to develop new treatments and diagnostics for diseases, as well as to improve crop yields and animal health. The Genomics market is composed of a variety of companies, ranging from large pharmaceutical companies to small start-ups. These companies are involved in the development of new technologies, such as gene editing, gene therapy, and gene sequencing, as well as the production of diagnostic tests and treatments. Some of the major players in the Genomics market include Illumina, Thermo Fisher Scientific, BGI, and Pacific Biosciences. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.